Literature DB >> 15047754

A tale of two sisters.

D R Gaya1, A L C McLay, K A Oien, R J Spooner, T G Reilly.   

Abstract

Hereditary haemochromatosis is the most common inherited disorder in white populations, whereas non-alcoholic steatohepatitis (NASH) is becoming the most common reason for referral for investigation of abnormal liver function tests (LFTs). This report describes two sisters, from similar environments, who were referred to the clinic after being found to be C282Y homozygotes and to have abnormal LFTs. One sister had developed features of haemochromatosis and the other had developed NASH. These cases illustrate the potential non-penetrance of HFE gene mutations and the need to investigate abnormal LFTs fully, even when there is a positive genetic test at the outset.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15047754      PMCID: PMC1770283          DOI: 10.1136/jcp.2003.012013

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  13 in total

1.  Prevalence of hemochromatosis-related symptoms among individuals with mutations in the HFE gene.

Authors:  Jill Waalen; Vincent Felitti; Terri Gelbart; Ngoc J Ho; Ernest Beutler
Journal:  Mayo Clin Proc       Date:  2002-06       Impact factor: 7.616

2.  The relation of iron status and hemochromatosis gene mutations in patients with chronic hepatitis C.

Authors:  L Kazemi-Shirazi; C Datz; T Maier-Dobersberger; K Kaserer; F Hackl; C Polli; P E Steindl; E Penner; P Ferenci
Journal:  Gastroenterology       Date:  1999-01       Impact factor: 22.682

3.  Expression of HLA-linked hemochromatosis in subjects homozygous or heterozygous for the C282Y mutation.

Authors:  D H Crawford; E C Jazwinska; L M Cullen; L W Powell
Journal:  Gastroenterology       Date:  1998-05       Impact factor: 22.682

4.  A simple genetic test identifies 90% of UK patients with haemochromatosis. The UK Haemochromatosis Consortium.

Authors: 
Journal:  Gut       Date:  1997-12       Impact factor: 23.059

5.  Nonalcoholic fatty liver disease: a feature of the metabolic syndrome.

Authors:  G Marchesini; M Brizi; G Bianchi; S Tomassetti; E Bugianesi; M Lenzi; A J McCullough; S Natale; G Forlani; N Melchionda
Journal:  Diabetes       Date:  2001-08       Impact factor: 9.461

6.  Penetrance of 845G--> A (C282Y) HFE hereditary haemochromatosis mutation in the USA.

Authors:  Ernest Beutler; Vincent J Felitti; James A Koziol; Ngoc J Ho; Terri Gelbart
Journal:  Lancet       Date:  2002-01-19       Impact factor: 79.321

7.  Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.

Authors:  C A Matteoni; Z M Younossi; T Gramlich; N Boparai; Y C Liu; A J McCullough
Journal:  Gastroenterology       Date:  1999-06       Impact factor: 22.682

8.  H63D mutation in the HFE gene increases iron overload in beta-thalassemia carriers.

Authors:  Maria Antonietta Melis; Milena Cau; Federica Deidda; Susanna Barella; Antonio Cao; Renzo Galanello
Journal:  Haematologica       Date:  2002-03       Impact factor: 9.941

9.  Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study.

Authors:  A Poonawala; S P Nair; P J Thuluvath
Journal:  Hepatology       Date:  2000-10       Impact factor: 17.425

10.  Nonalcoholic steatohepatitis: an expanded clinical entity.

Authors:  B R Bacon; M J Farahvash; C G Janney; B A Neuschwander-Tetri
Journal:  Gastroenterology       Date:  1994-10       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.